A group of __number__ children with advanced neuroblastoma ( __number__ Stage IV and __number__ Stage II), selected by their initial response to chemotherapy with pulsed cyclophosphamide/vincristine/Adriamycin (CVA), were given consolidation therapy with high-dose melphalan ( __number__ mg/m __number__ ) and then surgical removal of residual disease.